Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective
European Journal of Nuclear Medicine and Molecular Imaging · 2023
DOI: 10.1007/s00259-023-06157-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2023. Verfasst von Manon T A Vreeburg und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Nuclear Medicine, Sentinel Lymph Node, Melanoma, Penile Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lymph node (LN) metastasis is a relevant predictor for survival in patients with a.o. penile cancer (PeCa), malignant melanoma. The sentinel node (SN) procedure comprises targeted resection of the first tumour-draining SNs. Here, the hybrid tracer indocyanine green (ICG)- 99m Tc-nanocolloid has been used for several years to combine optical and nuclear detection. Recently, the resource of the nanocolloid precursor stopped production and the precursor was replaced by a different but chemically comparable colloid, nanoscan. Our aim was to study the performance of ICG- 99m Tc-nanoscan compared to ICG- 99m Tc-nanocolloid from a nuclear and surgical perspective.
Methods
Twenty-four patients with either PeCa or head-and-neck (H&N) melanoma and scheduled for a SN procedure were included. The initial group ( n = 11) received ICG- 99m Tc-nanocolloid until no longer available; the second group ( n = 13) received ICG- 99m Tc-nanoscan. Tracer uptake was assessed on lymphoscintigraphy and single-photon emission (SPECT). Intraoperatively, SNs were identified using gamma tracing and fluorescence imaging. Ex vivo (back-table) measurements were conducted to quantify the fluorescence emissions. Chemical analysis was performed to compare the ICG assembly on both precursors.
Results
The mean tracer uptake in the SNs was similar for ICG- 99m Tc-nanocolloid (2.2 ± 4.3%ID) and ICG- 99m Tc-nanoscan (1.8 ± 2.6%ID; p = 0.68). 3 SNs (interquartile range (IQR) 3–4) were detected on lymphoscintigraphy in PeCa patients receiving ICG- 99m Tc-nanoscan compared to 2 SNs (IQR 2–3) in PeCa patients receiving ICG- 99m Tc-nanocolloid ( p = 0.045), no differences were observed in H&N patients. Back-table measurements of resected SNs revealed a lower total fluorescence intensity in the ICG- 99m Tc-nanoscan group (24*10 9 arbitrary units (A.U) IQR 1.6*10 9 –14*10 9 in the ICG- 99m Tc-nanocolloid group versus 4.6*10 9 A.U. IQR 2.4*10 9 –42*10 9 in the ICG- 99m Tc-nanoscan group, p = 0.0054). This was consistent with a larger degree of “stacked” ICG observed in the nanoscan formulation. No tracer-related adverse events were reported.
Conclusions
Based on this retrospective analysis, we can conclude that ICG- 99m Tc-nanoscan has similar capacity for SN identification as ICG- 99m Tc-nanocolloid and can safely be implemented in SN procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
- Radiochemistry Facility, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
- Instrumentele zaken ontwikkeling, facilitair bedrijf, Leiden University Medical Centre, Leiden, The Netherlands.
- Department of Head and Neck Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
ORCID-Profile: Daphne D D Rietbergen
Zitieren
APA
Vreeburg, M. T. A., Azargoshasb, S., van Willigen, D., Molenaar, T., van Oosterom, M. N., Buckle, T., Slof, L. J., Klop, M., Karakullukcu, B., Donswijk, M., van der Poel, H. G., van Leeuwen, F. W. B., Brouwer, O. R., & Rietbergen, D. D. D. (2023). Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06157-9
Vancouver
Vreeburg MTA, Azargoshasb S, van Willigen D, Molenaar T, van Oosterom MN, Buckle T, et al. Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective. European Journal of Nuclear Medicine and Molecular Imaging. 2023. doi:10.1007/s00259-023-06157-9
BibTeX
@article{Vreeburg2023,
author = {Vreeburg, Manon T A and Azargoshasb, Samaneh and van Willigen, Danny and Molenaar, Tom and van Oosterom, Matthias N and Buckle, Tessa and Slof, Leon J and Klop, Martin and Karakullukcu, Baris and Donswijk, Maarten and van der Poel, Henk G and van Leeuwen, Fijs W B and Brouwer, Oscar R and Rietbergen, Daphne D D},
title = {Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2023},
doi = {10.1007/s00259-023-06157-9}
}
EUVIMED